What is Knownwell?
Hybrid primary care and obesity medicine designed around weight-inclusive care.
- Category
- Primary care and obesity medicine
- Headquarters
- Needham, MA
- Founded
- 2022
- Employees
- 51-200 reported range
- Total funding
- More than $50M
- Status
- Private; Series B
What is Knownwell?
Knownwell is a primary care and obesity medicine company. Knownwell offers in-person and virtual primary care, obesity medicine, nutrition, coaching, and GLP-1 support across Boston, Atlanta, Chicago, Dallas, New York, and nationwide virtual care.
Knownwell is a primary care and obesity medicine company with headquarters listed as Needham, MA. Hybrid primary care and obesity medicine designed around weight-inclusive care. Knownwell offers in-person and virtual primary care, obesity medicine, nutrition, coaching, and GLP-1 support across Boston, Atlanta, Chicago, Dallas, New York, and nationwide virtual care.
The company is currently best read as Private; Series B. Public sources show More than $50M in funding and Not publicly disclosed; where revenue, ARR, margin, or exact customer counts are not published, this profile avoids inventing them and uses funding, footprint, product coverage, and public scale signals instead.
For sellers, the account matters because buying centers span clinical operations, compliance, product, data, security, finance, and growth. The strongest pitch is tied to measurable access, quality, cost, workflow, or workforce outcomes rather than generic software adoption.
What does Knownwell offer?
Knownwell offers Primary care, Obesity medicine, GLP-1 care, Nutrition counseling, and related workflows.
- Primary care· Core product
- Obesity medicine· Core product
- GLP-1 care· Care workflow
- Nutrition counseling· Care workflow
- Health coaching· Expansion
- Nationwide virtual clinic· Expansion
How does Knownwell make money?
Knownwell bills care through insurance and payer/provider contracts while scaling clinics and virtual services; it explicitly says no sign-up fees or membership dues for patients.
Knownwell bills care through insurance and payer/provider contracts while scaling clinics and virtual services; it explicitly says no sign-up fees or membership dues for patients.
Patient costs depend on insurance coverage, visit type, and medication coverage; knownwell does not publish a cash-pay membership tier. Growth is driven by adoption in primary care and obesity medicine, expansion into larger accounts or additional geographies, and proof that the product improves outcomes, cost, capacity, or experience.
Because the company is private, this profile does not invent revenue, gross margin, or unit economics. Sellers should qualify budget owner, reimbursement model, procurement path, compliance requirements, and integration effort early.
Who leads Knownwell?
Knownwell is led by Brooke Boyarsky Pratt, Angela Fitch, MD, James Chaukos, Ben Taylor.
- Brooke Boyarsky PrattCEO & Co-founderFounderFormer McKinsey and Berkadia operator; founded knownwell after personal experience with weight bias.
- Angela Fitch, MDChief Medical Officer & Co-founderFounderObesity-medicine physician and former Obesity Medicine Association president.
- James ChaukosChief Operating OfficerCurrent executiveLeads operating scale across clinic and virtual care.
- Ben TaylorVP Business OperationsCurrent leaderSupports business operations and market expansion.
How do you contact Knownwell's leadership?
Knownwell does not publish verified personal executive emails in the reviewed public sources. Use official company contact, demo, support, partnerships, or careers routes rather than guessed personal emails.
Personal executive email format not verified; use official company routingHow much funding has Knownwell raised?
Knownwell has More than $50M in public or reported funding; latest disclosed round: Oct 2025 Series B ($25M).
Knownwell's disclosed funding history is: Jan 2023 Seed/early: undisclosed, valuation not disclosed, led/backed by a16z Bio + Health and Flare Capital Partners; Dec 2023 Series A: $20M, valuation not disclosed, led/backed by a16z Bio + Health, Flare, and others; Oct 2025 Series B: $25M, valuation not disclosed, led/backed by CVS Health Ventures.
The latest public valuation/status used here is Not publicly disclosed. If a valuation is not disclosed, this profile treats the company as private with no public priced mark rather than inferring a number from round size.
Seller signal: funding indicates capacity to invest, but healthcare buyers still require security, compliance, implementation proof, and outcomes evidence. New capital is most likely to support market expansion, hiring, product development, clinical operations, data, AI, and partnerships.
How did Knownwell get here?
Knownwell reached its current stage through founding, product expansion, and major financing milestones.
- 2022FoundedBrooke Boyarsky Pratt and Dr. Angela Fitch start knownwell.
- 2023a16z-backed launcha16z Bio + Health announces investment in knownwell.
- 2024Dallas expansionKnownwell begins national expansion of clinic and virtual services.
- Oct 2025$25M Series BCVS Health Ventures leads oversubscribed financing.
- 2026Nationwide virtual careKnownwell markets nationwide virtual care alongside regional clinics.
Who are Knownwell's competitors?
Knownwell competes with adjacent healthcare providers, software platforms, marketplaces, and care-navigation companies.
Knownwell — frequently asked questions
